Immunotech Biopharm Ltd's total assets for Q4 2024 were ¥564.04M, a decrease of -21.63% from the previous quarter. HK:6978 total liabilities were ¥580.50M for the fiscal quarter, a -9.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.